Matrine Enhances the Antitumor Efficacy of Chidamide in CTCL by Promoting Apoptosis.
Xinglan HeGuanyu WangYimeng WangChunlei Zhang
Published in: Recent patents on anti-cancer drug discovery (2024)
Our data have demonstrated chidamide combined with matrine to exhibit elevated antitumor activity in both CTCL cells and xenograft models of NOD/SCID mice, which may be a potential treatment option for CTCL.